Two-year outcomes of high bleeding risk patients with acute coronary syndrome after Biolimus A9 polymer-free drug-coated stents: a LEADERS FREE substudy
March 20, 2018 | 10.4244/EIJ-D-17-00720
Showing 1-2 of 2 articles
Coronary interventions
Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial September 18, 2016 | 10.4244/EIJV12I7A141